• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC).p53基因第72位密码子变异与遗传性非息肉病性结直肠癌(HNPCC)的发病年龄相关。
J Med Genet. 2005 Oct;42(10):769-73. doi: 10.1136/jmg.2004.028506.
2
The additive effect of p53 Arg72Pro and RNASEL Arg462Gln genotypes on age of disease onset in Lynch syndrome patients with pathogenic germline mutations in MSH2 or MLH1.p53基因Arg72Pro多态性与RNASEL基因Arg462Gln多态性对携带MSH2或MLH1致病种系突变的林奇综合征患者疾病发病年龄的累加效应。
Cancer Lett. 2007 Jul 8;252(1):55-64. doi: 10.1016/j.canlet.2006.12.006. Epub 2007 Jan 16.
3
Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study.前列腺癌易感基因RNASEL中的Arg462Gln序列变异与遗传性非息肉病性结直肠癌的发病年龄:一项病例对照研究。
Lancet Oncol. 2005 Aug;6(8):566-72. doi: 10.1016/S1470-2045(05)70253-9.
4
[The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].[匈牙利一个遗传性非息肉病性结直肠癌家系的首次分子分析:一种新的错配修复基因MSH2种系突变]
Orv Hetil. 2005 May 15;146(20):1009-16.
5
Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.与携带MLH1或MSH2突变的家族相比,27个携带致病性MSH6种系突变的家族中结直肠癌发病率较低且发病年龄较晚:德国遗传性非息肉病性结直肠癌联盟
J Clin Oncol. 2004 Nov 15;22(22):4486-94. doi: 10.1200/JCO.2004.02.033. Epub 2004 Oct 13.
6
Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.中国北方遗传性非息肉病性结直肠癌患者的微卫星不稳定性及新型错配修复基因突变
Chin J Dig Dis. 2006;7(4):197-205. doi: 10.1111/j.1443-9573.2006.00269.x.
7
Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.葡萄牙家族中结肠直肠癌与子宫内膜癌的关联,伴遗传性非息肉病性结直肠癌,显著增加了在错配修复基因(主要是MSH2基因)中检测到致病突变的可能性。
Cancer. 2004 Jul 1;101(1):172-7. doi: 10.1002/cncr.20320.
8
Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.基因转换是MLH1/MSH2缺失携带者患癌时野生型等位基因失活的常见机制。
Cancer Res. 2006 Jan 15;66(2):659-64. doi: 10.1158/0008-5472.CAN-05-4043.
9
Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.微卫星稳定、MSH2和MLH1突变阴性的遗传性非息肉病性结直肠癌患者的扩展微卫星分析:基因重新分类及其与临床特征的相关性
Digestion. 2004;69(3):166-76. doi: 10.1159/000078223. Epub 2004 Apr 28.
10
Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers.DNA错配修复基因MLH3中的种系和体细胞突变分析:结直肠癌中体细胞突变的证据。
Hum Mutat. 2001 May;17(5):389-96. doi: 10.1002/humu.1114.

引用本文的文献

1
Association of the rs1042522 SNP with prostate cancer risk: a study of cancer tissues, primary tumor cultures, and serum samples from a Spanish Caucasian population.rs1042522单核苷酸多态性与前列腺癌风险的关联:一项对西班牙白种人群的癌组织、原发性肿瘤培养物和血清样本的研究。
Front Oncol. 2024 Aug 13;14:1398411. doi: 10.3389/fonc.2024.1398411. eCollection 2024.
2
TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.台湾林奇综合征患者中TP53基因多态性与结直肠癌风险:一项回顾性队列研究
PLoS One. 2016 Dec 1;11(12):e0167354. doi: 10.1371/journal.pone.0167354. eCollection 2016.
3
The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies.TP53基因Arg72Pro多态性与结直肠癌的关联:基于32项研究的最新荟萃分析
Oncotarget. 2017 Jan 3;8(1):1156-1165. doi: 10.18632/oncotarget.13589.
4
Polymorphisms of cell cycle regulator genes G870A and C215G: Association with colorectal cancer susceptibility risk in a Malaysian population.细胞周期调节基因G870A和C215G的多态性:与马来西亚人群结直肠癌易感性风险的关联。
Oncol Lett. 2015 Nov;10(5):3216-3222. doi: 10.3892/ol.2015.3728. Epub 2015 Sep 18.
5
What's your poison? Impact of individual repair capacity on the outcomes of genotoxic therapies in cancer. Part II - information content and validity of biomarkers for individual repair capacity in the assessment of outcomes of anticancer therapy.你想要点什么?个体修复能力对癌症基因毒性疗法疗效的影响。第二部分——抗癌治疗疗效评估中个体修复能力生物标志物的信息内容和有效性。
Biotechnol Biotechnol Equip. 2014 Jan 2;28(1):2-7. doi: 10.1080/13102818.2014.902532.
6
TP53 alterations and colorectal cancer predisposition in south Indian population: a case-control study.印度南部人群中TP53改变与结直肠癌易感性:一项病例对照研究。
Tumour Biol. 2014 Mar;35(3):2303-11. doi: 10.1007/s13277-013-1305-y. Epub 2013 Oct 26.
7
Implication of DNA repair genes in prostate tumourigenesis in Indian males.印度男性前列腺肿瘤发生中 DNA 修复基因的意义。
Indian J Med Res. 2012 Oct;136(4):622-32.
8
TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.TP53 密码子 72 多态性与结直肠癌易感性的关系:荟萃分析。
Mol Biol Rep. 2011 Nov;38(8):4847-53. doi: 10.1007/s11033-010-0619-8. Epub 2010 Dec 8.
9
MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians.MDM2基因SNP309 T/G和p53基因SNP72 G/C不影响中欧高加索人中弥漫性大B细胞非霍奇金淋巴瘤的发病或生存情况。
BMC Cancer. 2008 Apr 23;8:116. doi: 10.1186/1471-2407-8-116.
10
Genetic variants in germline TP53 and MDM2 SNP309 are not associated with early onset colorectal cancer.种系TP53和MDM2 SNP309中的基因变异与早发性结直肠癌无关。
J Surg Oncol. 2008 Jun 1;97(7):621-5. doi: 10.1002/jso.20996.

p53基因第72位密码子变异与遗传性非息肉病性结直肠癌(HNPCC)的发病年龄相关。

The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC).

作者信息

Krüger S, Bier A, Engel C, Mangold E, Pagenstecher C, von Knebel Doeberitz M, Holinski-Feder E, Moeslein G, Schulmann K, Plaschke J, Rüschoff J, Schackert H K

机构信息

Department of Surgical Research, Dresden University of Technology, Germany.

出版信息

J Med Genet. 2005 Oct;42(10):769-73. doi: 10.1136/jmg.2004.028506.

DOI:10.1136/jmg.2004.028506
PMID:16199549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1735929/
Abstract

The polymorphic variants at codon 72 of the p53 gene were shown to be functionally distinct in vitro, whereby the arginine (arg) variant induces apoptosis more efficiently than the proline (pro) variant. From the evidence that the DNA mismatch repair system and p53 interact to maintain genomic integrity, we hypothesized that the codon 72 variation may influence the age of onset of disease in HNPCC patients. We tested 538 patients for p53 codon 72 variants, including 167 unrelated patients with pathogenic germline mutations in MSH2 or MLH1 and colorectal carcinoma as first tumour, 126 patients with sporadic microsatellite stable colorectal cancers, and 245 healthy controls. The median age of onset was 41, 36, and 32 years for MSH2 or MLH1 mutation carriers with arg/arg, arg/pro, and pro/pro genotypes, respectively. The log rank test revealed significant differences in the age of onset between arg/arg and pro/pro individuals (p = 0.0002) and in arg/pro versus arg/arg and pro/pro individuals (p = 0.0026 and p = 0.0217, respectively). A Cox regression model indicated an additive mode of inheritance. No significant differences in age of onset were observed among different genotype carriers with microsatellite stable tumours. Our results suggest that p53 codon 72 genotypes are associated with the age of onset of colorectal carcinoma in a mismatch repair deficient background in a dose dependent manner. These findings may be relevant for preventive strategies in HNPCC.

摘要

p53基因第72位密码子的多态性变体在体外显示出功能上的差异,其中精氨酸(arg)变体比脯氨酸(pro)变体更有效地诱导细胞凋亡。基于DNA错配修复系统与p53相互作用以维持基因组完整性的证据,我们推测第72位密码子的变异可能会影响HNPCC患者的发病年龄。我们对538名患者进行了p53第72位密码子变体检测,包括167名携带MSH2或MLH1致病种系突变且首发肿瘤为结直肠癌的无亲缘关系患者、126名散发性微卫星稳定型结直肠癌患者以及245名健康对照者。对于携带arg/arg、arg/pro和pro/pro基因型的MSH2或MLH1突变携带者,发病年龄的中位数分别为41岁、36岁和32岁。对数秩检验显示,arg/arg与pro/pro个体之间的发病年龄存在显著差异(p = 0.0002),arg/pro与arg/arg及pro/pro个体之间也存在显著差异(分别为p = 0.0026和p = 0.0217)。Cox回归模型表明存在加性遗传模式。在微卫星稳定型肿瘤的不同基因型携带者中,未观察到发病年龄的显著差异。我们的结果表明,在错配修复缺陷背景下,p53第72位密码子基因型与结直肠癌的发病年龄呈剂量依赖性相关。这些发现可能与HNPCC的预防策略相关。